When does West Pharmaceutical Services report earnings?

West Pharmaceutical Services, Inc. · end-of-day data as of Nov 13, 2026

West Pharmaceutical Services

WST · $29.01B

$416.42+1.2%

Nov 13, 2026 · close

▲ 3

ConsensusBuy · 16
MAs4 of 4
Sector▲ +15.9%

Neutral

Earnings in90d
P/E46.7x
RSI66
Support-12.7%
Off 52w high-5.0%
Volume0.6x
Bollingerupper half
News0.00
FCF yield+1.6%
Trendsideways
52w range$224–$438
ATR+2.5%
Off ATH-12.4%

▼ 5

PT$413.38 -0.7%
P/E vs own+15.8%
P/E vs sector+45.1%
Insiders-$3.52M
MACD-0.08

Updates with the 15-min delayed price. Not a forecast or investment advice.

West Pharmaceutical Services WST reports its next earnings on Thursday, Feb 11, 2027, before the open, an estimated date the company has not confirmed yet. Analysts expect EPS of $2.27 on revenue of $825M. West Pharmaceutical Services beat the EPS estimate in 8 of its last 8 reports, and the stock moved ±11.7% on average the session after. The last report, on Oct 29, 2026: EPS of $2.66 against $2.20 expected and revenue of $875M against $827M; the stock rose 3.2% the next session.

The stock around its reports

Last close $416.42 · +28.0% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue +8.7% year over year, free cash flow 17.2% of revenue, operating margin 30.6%.

RevenueFree cash flow


Q3 FY2026	Sep 30, 2026	$875M	3.02	$150M	39.7%	30.6%	24.5%
Q2 FY2026	Jun 30, 2026	$872M	2.15	$80.8M	37.7%	20.5%	17.7%
Q1 FY2026	Mar 31, 2026	$845M	1.92	$47.2M	35.1%	21.0%	16.4%
Q4 FY2025	Dec 31, 2025	$805M	1.82	$175M	37.8%	19.5%	16.4%
Q3 FY2025	Sep 30, 2025	$804M	1.93	$134M	36.5%	21.6%	17.4%
Q2 FY2025	Jun 30, 2025	$766M	1.82	$102M	35.7%	20.6%	17.2%
Q1 FY2025	Mar 31, 2025	$698M	1.23	$58.1M	33.3%	18.4%	12.9%
Q4 FY2024	Dec 31, 2024	$749M	1.78	$85.2M	36.7%	22.8%	17.4%